Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative

Alexey A Rumyantsev¹, Alexandra S Tyulyandina¹, Alexey A Tryakin¹, Mikhail Y Fedyanin¹, Sergey A Tjulandin¹

Affiliations

Affiliation

¹ Alexey A. Rumyantsev, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia; Alexandra S. Tyulyandina, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, Sechenov First Moscow Medical University (Sechenov University), Moscow, Russia; Alexey A. Tryakin, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, Bashkir State Medical University, Ufa, Russia; Mikhail Y. Fedyanin, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, Moscow Medical City Hospital "Kommunarka," Moscow, Russia, N.I. Pirogov National Medical and Surgical Center, Moscow, Russia; and Sergey A. Tjulandin, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.

PMID: 37677119
DOI: 10.1200/JCO.23.00629

Comment

Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative

Alexey A Rumyantsev et al. J Clin Oncol. 2023.

. 2023 Nov 20;41(33):5202-5203.

doi: 10.1200/JCO.23.00629. Epub 2023 Sep 7.

Authors

Alexey A Rumyantsev¹, Alexandra S Tyulyandina¹, Alexey A Tryakin¹, Mikhail Y Fedyanin¹, Sergey A Tjulandin¹

Affiliation

¹ Alexey A. Rumyantsev, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia; Alexandra S. Tyulyandina, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, Sechenov First Moscow Medical University (Sechenov University), Moscow, Russia; Alexey A. Tryakin, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, Bashkir State Medical University, Ufa, Russia; Mikhail Y. Fedyanin, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia, Moscow Medical City Hospital "Kommunarka," Moscow, Russia, N.I. Pirogov National Medical and Surgical Center, Moscow, Russia; and Sergey A. Tjulandin, MD, PhD, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.

PMID: 37677119
DOI: 10.1200/JCO.23.00629

No abstract available

PubMed Disclaimer

Comment in

Reply to A. Rumyantsev et al.
Daneshmand S, Hu B, Nichols C. Daneshmand S, et al. J Clin Oncol. 2023 Nov 20;41(33):5203-5204. doi: 10.1200/JCO.23.01148. Epub 2023 Sep 7. J Clin Oncol. 2023. PMID: 37677112 No abstract available.

Comment on

Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
Daneshmand S, Cary C, Masterson T, Einhorn L, Adra N, Boorjian SA, Kollmannsberger C, Schuckman A, So A, Black P, Bagrodia A, Skinner E, Alemozaffar M, Brand T, Eggener S, Pierorazio P, Stratton K, Nappi L, Nichols C, Luo C, Li M, Hu B. Daneshmand S, et al. J Clin Oncol. 2023 Jun 1;41(16):3009-3018. doi: 10.1200/JCO.22.00624. Epub 2023 Mar 13. J Clin Oncol. 2023. PMID: 36913642 Clinical Trial.

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative

Affiliation

Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative

Authors

Affiliation

Comment in

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical